# Atossa Therapeutics, Inc.: Form DEF 14A, filed May 23, 2024

- Company: [Atossa Therapeutics, Inc.](/companies/atos.md) (CIK 1488039)
- Form: DEF 14A
- Filed: 2024-05-23
- Accepted by EDGAR: May 23, 2024, 13:00 ET
- Period: 2024-05-23
- Accession: 0000950170-24-063763
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1488039/000095017024063763/atos_def14a_2024.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1488039/000095017024063763/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1488039/000095017024063763/atos_def14a_2024.htm

Filed May 23, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-063763. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.